FDA Adverse Event Injury Summary report: N

EUFLEXXA

MDR report key: 4543706 · Received February 23, 2015

Report

Report Number
3000164186-2015-00011
Event Type
Injury
Date Received
February 23, 2015
Date of Event
January 12, 2015
Report Date
January 26, 2015
Manufacturer
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
Product Code
MOZ
PMA / PMN Number
P010029
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

INFECTION TO THE RIGHT KNEE/METHICILLIN SENSITIVE STAPH AUREUS (MSSA) (B)(6) JOINT SWELLING]; RIGHT KNEE VERY PAINFUL [ARTHRALGIA]; RIGHT KNEE WARM TO TOUCH [JOINT WARMTH]; UNABLE TO STRAIGHTEN UP THE RIGHT KNEE [JOINT RANGE OF MOTION DECREASED]. CASE DESCRIPTION: THIS SERIOUS SPONTANEOUS DEVICE REPORT WAS RECEIVED FROM A NURSE IN THE UNITED STATES. A PATIENT, A (B)(6) MALE EXPERIENCED INFECTION OF THE RIGHT KNEE AND THE RIGHT KNEE WAS VERY SWOLLEN, VERY PAINFUL, WARM TO TOUCH, AND UNABLE TO STRAIGHTEN IT UP AFTER RECEIVING THE EUFLEXXA INTRA-ARTICULAR INJECTIONS (1% SODIUM HYALURONATE) ONCE A WEEK FOR THREE WEEKS TO BOTH KNEES FOR KNEE PAIN. LOT NUMBER : K10183A AND EXPIRATION DATE: 20 JULY 2015. IN 2012, 2013, AND 2014 THE PATIENT RECEIVED SERIES OF EUFLEXXA INJECTIONS WITHOUT ANY HISTORY OF ANY REACTIONS. ON (B)(6) 2015, THE MALE PATIENT INITIATED EUFLEXXA THERAPY AND RECEIVED HIS FIRST INTRA-ARTICULAR INJECTION. ON (B)(6), THE PATIENT RECEIVED HIS SECOND EUFLEXXA INJECTION. IN THE EVENING OF (B)(6) 2015, THE PATIENT STARTED TO EXPERIENCE RIGHT KNEE INFECTION, WAS VERY SWOLLEN, VERY PAINFUL, WARM TO TOUCH, AND WAS UNABLE TO STRAIGHTEN UP THE RIGHT KNEE. ON (B)(6) 2015, THE PATIENT WENT TO THE EMERGENCY ROOM AND ON THE SAME DAY, THE PATIENT UNDERWENT SURGERY TO THE RIGHT KNEE AND WAS DIAGNOSED WITH (B)(6) TO THE RIGHT KNEE. ON (B)(6) 2015, THE PATIENT UNDERWENT ANOTHER SURGERY FOR IRRIGATION AND DEBRIDEMENT. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2015. AS PER REPORTING NURSE, THE PHYSICIAN STRONGLY FELT THAT THE REPORTED EVENT INFECTION TO THE RIGHT KNEE WAS RELATED TO EUFLEXXA. DUE TO THE EVENTS, EUFLEXXA INJECTION WAS DISCONTINUED. AT THE TIME OF REPORTING, THE PATIENT HAD NOT RECOVERED FROM THE REPORTED EVENTS. MEDICAL HISTORY WAS PROVIDED AND INCLUDED PRIOR HISTORY OF RECEIVING OTHER INJECTION (DRUG NAME UNKNOWN) TO THE KNEES IN 2009 AND 2010. CONCOMITANT MEDICATIONS WERE PROVIDED. SENDER COMMENT: REPORTER CAUSALITY: RELATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
126697 EUFLEXXA 1% SODIUM HYALURONATE MOZ BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. K10183A

Patients

Seq Age Sex Outcome Treatment
1 70 YR Hospitalization IBUPROFEN (IBUPROFEN)| AMLODIPINE BESILATE (AMLODIPINE BESILATE),| LOVASTATIN (LOVASTATIN),